Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Neurofibroma

fluorodeoxyglucose f18 has been researched along with Neurofibroma in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's0 (0.00)18.2507
2000's7 (50.00)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beigelman, C; Boulanger, X; Brun, AL; Ledoux, JB1
Dry, SM; Eilber, FC; James, AW; Shurell, E; Singh, A1
Choe, YH; Chung, MJ; Jin, GY; Kim, HJ; Kim, SR; Lee, HB; Lee, YC; Park, SJ1
Aly, A; Azad, A; Chong, G; Tauro, A; Tebbutt, NC1
Ao, Y; Dang, J; Dry, SM; Eilber, FC; Gregorian, C; Lawson, G; Liu, X; Mellinghoff, IK; Mischel, PS; Nakashima, J; Nghiemphu, PL; Parada, LF; Phelps, M; Smith, KB; Sofroniew, MV; Wu, H1
Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Elashoff, D; Phelps, ME; Tap, WD; Weber, WA1
Guha, A; Hendler, A; Karabatsou, K; Kiehl, TR; Wilson, DM1
Bonenkamp, HJ; de Geus-Oei, LF; de Rooy, JW; Flucke, UE; van de Luijtgaarden, AC; van der Graaf, WT1
Iwasaki, T; Kawahara, K; Ohta, M; Okimura, A1
Attigah, N; Cardona, S; Dimitrakopoulou-Strauss, A; Hinz, U; Lehnert, T; Mechtersheimer section sign, G; Schwarzbach, M1
Fang, CL; Hsu, CH; Lee, CM; Wang, FC1
Bingham, J; Cronin, BF; Ferner, RE; Hughes, RA; Lucas, JD; O'Doherty, MJ; Smith, MA1
Donnemiller, E; Erler, H; Gabriel, M; Riccabona, G1
Brunetti, A; Chang, AE; Finn, RD; Kern, KA; Lack, E; Larson, SM; Malawer, M; Norton, JA; Rosenberg, SA1

Reviews

3 review(s) available for fluorodeoxyglucose f18 and Neurofibroma

ArticleYear
Imaging of the non-traumatic brachial plexus.
    Diagnostic and interventional imaging, 2013, Volume: 94, Issue:10

    Topics: Brachial Plexus; Brachial Plexus Neuropathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Nerve Compression Syndromes; Neurilemmoma; Neurofibroma; Neurologic Examination; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiation Injuries; Reference Values; Sensitivity and Specificity; Syndrome; Thoracic Outlet Syndrome

2013
Malignant Peripheral Nerve Sheath Tumor.
    Surgical oncology clinics of North America, 2016, Volume: 25, Issue:4

    Topics: Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma

2016
Intrapulmonary neurofibroma independent of neurofibromatosis type 1.
    General thoracic and cardiovascular surgery, 2012, Volume: 60, Issue:3

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neurofibroma; Neurofibromatosis 1; Pneumonectomy; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed; Treatment Outcome

2012

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Neurofibroma

ArticleYear
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
    Cancer, 2010, Jan-15, Volume: 116, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity

2010

Other Studies

10 other study(ies) available for fluorodeoxyglucose f18 and Neurofibroma

ArticleYear
Solitary neurofibroma of intercostal region in a patient without neurofibromatosis type 1.
    The American journal of the medical sciences, 2008, Volume: 336, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Thoracic Wall; Tomography, X-Ray Computed

2008
18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:2

    Topics: Aged; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma; Positron-Emission Tomography

2010
PTEN dosage is essential for neurofibroma development and malignant transformation.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-17, Volume: 106, Issue:46

    Topics: Animals; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Dosage; Humans; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neurofibroma; Oncogene Protein p21(ras); Positron-Emission Tomography; PTEN Phosphohydrolase; raf Kinases

2009
Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Neurosurgery, 2009, Volume: 65, Issue:4 Suppl

    Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nerves; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Tomography, X-Ray Computed; Young Adult

2009
Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:4

    Topics: Cell Transformation, Neoplastic; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Young Adult

2010
Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2003, Volume: 29, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed

2003
Neurofibroma with increased uptake of [F-18]-fluoro-2 deoxy-D-glucose interpreted as a metastatic lesion.
    Annals of nuclear medicine, 2003, Volume: 17, Issue:7

    Topics: Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Intercostal Nerves; Mediastinal Neoplasms; Middle Aged; Neurofibroma; Peripheral Nervous System Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms

2003
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
    Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibroma; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Tomography, Emission-Computed

2000
Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.
    Nuklearmedizin. Nuclear medicine, 2002, Volume: 41, Issue:2

    Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibroma; Radiopharmaceuticals; Thyroid Neoplasms; Tissue Distribution; Tomography, Emission-Computed

2002
Metabolic imaging of human extremity musculoskeletal tumors by PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1988, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Child; Deoxyglucose; Female; Femoral Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Giant Cell Tumors; Histiocytoma, Benign Fibrous; Humans; Leg; Liposarcoma; Male; Middle Aged; Neurofibroma; Soft Tissue Neoplasms; Tomography, Emission-Computed

1988